Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Army
Johnson and Johnson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,034,267

« Back to Dashboard

Summary for Patent: 6,034,267

Title: Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
Abstract:The invention provides a pharmaceutical compositions comprising a compound of formula I: wherein, R.sup.1 and R.sup.2 have any of the values defined in the specification; or a salt thereof; and a pharmaceutically acceptable carrier or excipient. The invention also provides a method for the diagnosis or photochemotherapeutic treatment of disorders or abnormalities of external or internal surfaces of the body using such compounds or salts.
Inventor(s): Gierskcky; Karl E. (Oslo, NO), Moan; Johan (Oslo, NO), Peng; Qian (Oslo, NO), Steen; Harald (Oslo, NO), Warloe; Trond (Oslo, NO), Bjorseth; Alf (Oslo, NO)
Assignee: PhotoCure AS (Olso, NO)
Application Number:08/913,257
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Device;

No matches for this query

Foreign Priority and PCT Information for Patent: 6,034,267

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9504948Mar 10, 1995
United Kingdom9525822Dec 18, 1995
PCT Information
PCT FiledMarch 08, 1996PCT Application Number:PCT/GB96/00553
PCT Publication Date:September 19, 1996PCT Publication Number: WO96/28412

International Patent Family for Patent: 6,034,267

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Netherlands300207► Subscribe
Germany122006000051► Subscribe
European Patent Office0820432► SubscribeSPC024/2002Ireland► Subscribe
European Patent Office0820432► SubscribeSPC/GB02/038United Kingdom► Subscribe
European Patent Office0820432► Subscribe300176Netherlands► Subscribe
European Patent Office0820432► Subscribe300207Netherlands► Subscribe
European Patent Office0820432► SubscribeSPC/GB05/044United Kingdom► Subscribe
European Patent Office0820432► Subscribe05C0042France► Subscribe
European Patent Office0820432► Subscribe07C0010France► Subscribe
European Patent Office0820432► SubscribeSPC019/2008Ireland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus